Final results from SAUL, a single-arm international real-world study of atezolizumab in 1004 patients with pretreated locally advanced/metastatic urinary tract carcinoma
Descubra más ventajas exclusivas con el portal especializado
Descubra más ventajas exclusivas con el portal especializado
Final results from SAUL, a single-arm international real-world study of atezolizumab in 1004 patients with pretreated locally advanced/metastatic urinary tract carcinoma